Antibiotic resistance among bacteria isolated from war-wounded patients at the Weapon Traumatology Training Center of the International Committee of the Red Cross from 2016 to 2019: a secondary analysis of WHONET surveillance data

Abstract

Background A substantial body of evidence has recently emphasized the risks associated with antibiotic resistance (ABR) in conflicts in the Middle East. War-related, and more specifically weapon-related wounds can be an important breeding ground for multidrug resistant (MDR) organisms. However, the majority of available evidence comes from the military literature focused on risks and patterns of ABR in infections from combat-related injuries among military personnel. The overall aim of this study is to contribute to the scarce existing evidence on the burden of ABR among patients, including civilians with war-related wounds in the Middle East, in order to help inform the revision of empirical antibiotic prophylaxis and treatment protocols adopted in these settings. The primary objectives of this study are to: 1) describe the microbiology and the corresponding resistance profiles of the clinically relevant bacteria most commonly isolated from skin, soft tissue and bone biopsies in patients admitted to the WTTC; and 2) describe the association of the identified bacteria and corresponding resistance profiles with sociodemographic and specimen characteristics. Methods We retrospectively evaluated the antibiograms of all consecutive, non-duplicate isolates from samples taken from patients admitted to the ICRC WTTC between 2016 and 2019, limited to skin and soft tissue samples and bone biopsies. We collected data on socio-demographic characteristics from patient files and data on specimens from the WHONET database. We ran univariate and multivariable logistic regression models to test the association between bacterial and resistance profiles with sociodemographic and specimen characteristics. Results Patients who were admitted with war-related trauma to the ICRC reconstructive surgical project in Tripoli, Lebanon, from 2016 to 2019, presented with high proportion of MDR in the samples taken from skin and soft tissues and bones, particularly Enterobacterales (44.6%), MRSA (44.6%) and P. aeruginosa (7.6%). The multivariable analysis shows that the odds of MDR isolates were higher in Iraqi patients (compared to Syrian patients) and in Enterobacterales isolates (compared to S. aureus isolates). Conclusions Our findings stress the importance of regularly screening patients who present with complex war-related injuries for colonization with MDR bacteria, and of ensuring an antibiotic-sensitivity testing-guided antimicrobial therapeutic approach.

Antibiotic susceptibility patterns at the Médecins Sans Frontières (MSF) Acute Trauma Hospital in Aden, Yemen: a retrospective study from January 2018 to June 2021

“… 25 Moreover, in a surgery hospital in Lebanon, treating acute and chronic war-related trauma patients, predominantly from the Syrian war, where S. aureus (49.1%) was the most commonly isolated bacterium, followed by Enterobacterales (28.5%) and P. aeruginosa (13.2%) but only from bone and tissue samples. 26 …”

“…The prevalence of MRSA across conflict regions is generally high, 29 with a range of MRSA from all S. aureus isolates of 72.6% in our hospital to 95.4% in Mosel, Iraq 25 and 48.5% in one of Lebanon’s studies. 26 …”

A Narrative Review of Healthcare-Associated Gram-Negative Infections Among Pediatric Patients in Middle Eastern Countries

“…For instance, the impact on AMR rates from expatriate workers in GCC countries is highlighted by a 2-year study conducted in Kuwait evaluating antibiotic resistance among food handlers, where a majority of workers (86%) were non-Arab [ 75 ]. Moreover, countries with war-wounded civilians such as Syria and Iraq have become a major source of MDR bacteria that have spread not only to neighboring countries, but also globally [ 76 , 77 ]. The protracted Syrian conflict has led to one of the largest global refugee crises, with 5.6 million refugees mainly fleeing to neighboring countries such as Turkey, Lebanon, and Jordan [ 78 ].…”

Antibody-conjugated and streptomycin-chitosan oligosaccharide-modified gold nanoshells for synergistic chemo-photothermal therapy of drug-resistant bacterial infection

“…Pathogenic bacterial infections are an escalating global public health problem and cause a huge medical and economic burden because of the emergence of multidrug-resistant bacteria as well as the rapid emergence of new infections, which are still the leading cause of death worldwide [1] , [2] , [3] . Treatment with antibiotics is the most common and efficient strategy for treating and preventing bacterial infections [4] .…”